Applicant, as named in the Orange Book

Astrazeneca

Next listed expiry: Airsupra on 28 May 2030. 13 products with live protection, 10 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Airsupra albuterol sulfate; budesonide	albuterol sulfate; budesonide	214070	28 May 2030	patent, carve-out possible
Symbicort Aerosphere · 2 strengths budesonide; formoterol fumarate	budesonide; formoterol fumarate	216579	28 May 2030	patent
Bevespi Aerosphere formoterol fumarate; glycopyrrolate	formoterol fumarate; glycopyrrolate	208294	17 Mar 2031	patent, carve-out possible
Koselugo · 2 strengths selumetinib sulfate	selumetinib sulfate	219943	19 Nov 2032	exclusivity
Koselugo · 2 strengths selumetinib sulfate	selumetinib sulfate	213756	19 Nov 2032	exclusivity
Truqap · 2 strengths capivasertib	capivasertib	218197	16 Apr 2033	patent
Lokelma · 2 strengths sodium zirconium cyclosilicate	sodium zirconium cyclosilicate	207078	14 Oct 2035	patent
Calquence acalabrutinib maleate	acalabrutinib maleate	216387	1 Jul 2036	patent
Calquence acalabrutinib	acalabrutinib	210259	1 Jul 2036	patent
Brilinta · 2 strengths ticagrelor	ticagrelor	022433	27 Jul 2036	patent
Etcamah camizestrant	camizestrant	220359	22 Oct 2041	patent
Lynparza · 2 strengths olaparib	olaparib	208558	25 Oct 2041	patent, carve-out possible
Tagrisso · 2 strengths osimertinib mesylate	osimertinib mesylate	208065	26 Nov 2042	patent, carve-out possible

Recent events

25 Oct 2026Nexium · Generic approved 25 Sep 2026
25 Oct 2026Brilinta · Generic approved 6 Feb 2026
25 Oct 2026Brilinta · Generic approved 24 Mar 2026
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 20 Aug 2026
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Lokelma · First generic approved 7 Aug 2026
25 Oct 2026Lokelma · Generic approved 7 Aug 2026
25 Oct 2026Brilinta · Generic approved 27 Apr 2026
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
25 Oct 2026Symbicort · Generic approved 23 Apr 2026
25 Oct 2026Nexium · Generic approved 25 Sep 2026
25 Oct 2026Brilinta · Generic approved 28 Oct 2025
24 Oct 2026Lynparza · Exclusivity expires within 90 days ODE-28327 Dec 2026
24 Oct 2026Lynparza · Exclusivity expires within 90 days ODE-28327 Dec 2026
24 Oct 2026Calquence · Exclusivity expires within 90 days ODE-27421 Nov 2026

Products without listed protection (10)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Crestor · 4 strengths rosuvastatin calcium	rosuvastatin calcium	021366	open now	no listed protection
Daliresp · 2 strengths roflumilast	roflumilast	022522	open now	no listed protection
Faslodex fulvestrant	fulvestrant	021344	open now	no listed protection
Iressa gefitinib	gefitinib	206995	open now	no listed protection
Nexium · 2 strengths esomeprazole magnesium	esomeprazole magnesium	021153	open now	no listed protection
Nexium · 4 strengths esomeprazole magnesium	esomeprazole magnesium	021957	open now	no listed protection
Nexium esomeprazole magnesium	esomeprazole magnesium	022101	open now	no listed protection
Prilosec Otc omeprazole magnesium	omeprazole magnesium	021229	open now	no listed protection
Pulmicort Respules · 3 strengths budesonide	budesonide	020929	open now	no listed protection
Symbicort · 2 strengths budesonide; formoterol fumarate dihydrate	budesonide; formoterol fumarate dihydrate	021929	open now	no listed protection